Similar articles

• Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).

  Loubatiéres A, Mariani MM, Ribes G, Alric R. Loubatiéres A, et al. Acta Diabetol Lat. 1973 Mar-Apr;10(2):261-82. Acta Diabetol Lat. 1973. PMID: 4200675 No abstract available.
• [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].

  Loubatières A, Ribes G, Mariani MM, Alric R. Loubatières A, et al. Acta Diabetol Lat. 1973 Mar-Apr;10(2):261-82. Acta Diabetol Lat. 1973. PMID: 4200420 Italian. No abstract available.
• The pharmacology of S 1702, a new highly effective oral antibiabetic drug with unusual properties. 1. Pharmacological and hypoglycaemic activity, studies in different animal species.

  Duhault J, Boulanger M, Tisserand F, Bergi L. Duhault J, et al. Arzneimittelforschung. 1972 Oct;22(10):1682-5. Arzneimittelforschung. 1972. PMID: 4677056 No abstract available.
• [Hypoglycemic sulfonamides].

  Loubatières AL. Loubatières AL. Actual Pharmacol (Paris). 1968;21:173-90. Actual Pharmacol (Paris). 1968. PMID: 4888764 Review. French. No abstract available.
• [Mode of action of blood glucose lowering sulfonamides. Other extrapancreatic effects].

  Madsen J. Madsen J. Acta Diabetol Lat. 1969 Sep;6 Suppl 1:415-28. Acta Diabetol Lat. 1969. PMID: 4906023 Review. Multiple languages. No abstract available.